Investment Sales

Chris Lashmet

Managing Director
Medical & Life Sciences
Schedule a Meeting
About

Chris Lashmet joined Berkadia in 2022 and is a Managing Director of Investment Sales based in Chicago, IL, with a specialization in Medical & Life Sciences. Chris focuses his efforts building relationships and advising on how to maximize the value of their properties by coming up with specific strategies and how to implement them. His comprehensive experience on both the principal and advisory side of the business provides a unique perspective to the industry.

Prior to Berkadia, Mr. Lashmet co-led the Medical Office group at Blueprint Healthcare Real Estate Advisors with his business partner Eric Lee. Together, they founded the new division at Blueprint, grew a team, and experienced significant early success in the market. They closed 20 medical office transactions valued at $170 million during their tenure at Blueprint across various deal profiles, spread throughout the country. Prior to Blueprint Healthcare Real Estate Advisors, Lashmet worked on the investments teams at Ventas REIT and MedProperties Group, where he focused on acquisitions and development of medical office buildings, life science and senior housing profiles.

Before Lashmet started his business career, he was drafted by the Pittsburgh Pirates in 2011 where he played professional baseball for three seasons. Lashmet received his bachelor’s degree in economics and business from Northwestern University. He is still involved at the university as an NU For Life Purple Mentor.

Education & Certifications

  • B.A. in Economics, Northwestern University
  • Licensed Real Estate Broker, Illinois

Affiliations & Memberships

  • Inaugural Member, Revista Rising Leaders Council

Awards & Notability

  • Pittsburgh Pirate Player (2011-2013)
Show More
Show Less
NewsAll News

3121 N. Sheridan Road, Chicago, IL | Sold by Berkadia 2026

Read More
ResearchAll Research

Berkadia 2026 Multifamily Forecast Market Report – Chicago

Download Now
ResearchAll Research

Berkadia Q3 2025 Multifamily Market Report – Detroit

Download Now
ResearchAll Research

Berkadia Q3 2025 Multifamily Market Report – Chicago

Download Now

NewsAll News

3121 N. Sheridan Road, Chicago, IL | Sold by Berkadia 2026

Read More

ResearchAll Research

Berkadia 2026 Multifamily Forecast Market Report – Chicago

Download Now

ResearchAll Research

Berkadia Q3 2025 Multifamily Market Report – Detroit

Download Now

ResearchAll Research

Berkadia Q3 2025 Multifamily Market Report – Chicago

Download Now
Close